Cited 13 time in
Polymeric vehicles for topical delivery and related analytical methods
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Cho, Heui Kyoung | - |
| dc.contributor.author | Cho, Jin Hun | - |
| dc.contributor.author | Jeong, Seong Hoon | - |
| dc.contributor.author | Cho, Dong Chul | - |
| dc.contributor.author | Yeum, Jeong Hyun | - |
| dc.contributor.author | Cheong, In Woo | - |
| dc.date.accessioned | 2024-08-08T05:00:59Z | - |
| dc.date.available | 2024-08-08T05:00:59Z | - |
| dc.date.issued | 2014-04 | - |
| dc.identifier.issn | 0253-6269 | - |
| dc.identifier.issn | 1976-3786 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/18250 | - |
| dc.description.abstract | Recently a variety of polymeric vehicles, such as micelles, nanoparticles, and polymersomes, have been explored and some of them are clinically used to deliver therapeutic drugs through skin. In topical delivery, the polymeric vehicles as drug carrier should guarantee non-toxicity, long-term stability, and permeation efficacy for drugs, etc. For the development of the successful topical delivery system, it is of importance to develop the polymeric vehicles of well-defined intrinsic properties, such as molecular weights, HLB, chemical composition, topology, specific ligand conjugation and to investigate the effects of the properties on drug permeation behavior. In addition, the role of polymeric vehicles must be elucidated in in vitro and in vivo analyses. This article describes some important features of polymeric vehicles and corresponding analytical methods in topical delivery even though the application span of polymers has been truly broad in the pharmaceutical fields. | - |
| dc.format.extent | 12 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | PHARMACEUTICAL SOC KOREA | - |
| dc.title | Polymeric vehicles for topical delivery and related analytical methods | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.1007/s12272-014-0342-4 | - |
| dc.identifier.scopusid | 2-s2.0-84897508261 | - |
| dc.identifier.wosid | 000333695800001 | - |
| dc.identifier.bibliographicCitation | ARCHIVES OF PHARMACAL RESEARCH, v.37, no.4, pp 423 - 434 | - |
| dc.citation.title | ARCHIVES OF PHARMACAL RESEARCH | - |
| dc.citation.volume | 37 | - |
| dc.citation.number | 4 | - |
| dc.citation.startPage | 423 | - |
| dc.citation.endPage | 434 | - |
| dc.type.docType | Review | - |
| dc.identifier.kciid | ART001901960 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.subject.keywordPlus | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | - |
| dc.subject.keywordPlus | PEO TRIBLOCK COPOLYMERS | - |
| dc.subject.keywordPlus | TRANSDERMAL DELIVERY | - |
| dc.subject.keywordPlus | STRATUM-CORNEUM | - |
| dc.subject.keywordPlus | ENCAPSULATION EFFICIENCY | - |
| dc.subject.keywordPlus | SKIN PENETRATION | - |
| dc.subject.keywordPlus | IN-VIVO | - |
| dc.subject.keywordPlus | AMPHIPHILIC DIBLOCK | - |
| dc.subject.keywordPlus | BLOCK-COPOLYMERS | - |
| dc.subject.keywordPlus | BARRIER FUNCTION | - |
| dc.subject.keywordAuthor | Polymeric vehicles | - |
| dc.subject.keywordAuthor | Topical delivery | - |
| dc.subject.keywordAuthor | Skin permeation | - |
| dc.subject.keywordAuthor | Block copolymers | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
